Remove 2006 Remove Pharmacy Remove Testimonials
article thumbnail

SAVE THE DATE: Drug Channels Leadership Forum, March 16-18, 2026

Drug Channels

Jeanine Robertson, Director of Pharmacy Network Relations, Liviniti WHAT TO EXPECT Expect bold, candid discussionsnot just presentations. Jason Dombi, Senior Vice President of Strategic Solutions, Cencora WATCH HIGHLIGHTS FROM DCLF 2025 Relive the #DCLF2025 energy and hear testimonials directly from participants. Click here.

article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

2006), app. In at least the short term, a popular pain reliever would have to be removed from pharmacies. 7, 2022), which addressed the same question in the context of the admissibility of expert testimony. Therefore, Davis excluded as “not relevant” expert testimony about non-FDA-approved alternatives. 2d 839, 851 (N.Y.

FDA 59